Grupo Financiero Galicia: Q1 Earnings Snapshot
BUENOS AIRES, Argentina (AP) — BUENOS AIRES, Argentina (AP) — Grupo Financiero Galicia SA (GGAL) on Tuesday reported first-quarter earnings of $154.1 million.
The Buenos Aires, Argentina-based bank said it had earnings of 96 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 90 cents per share.
The financial services provider posted revenue of $2.18 billion in the period. Its revenue net of interest expense was $1.51 billion, which did not meet Street forecasts.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GGAL at https://www.zacks.com/ap/GGAL
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Brunswick Exploration Announces AGM Results
MONTREAL, June 12, 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. ('BRW' or the 'Corporation') is pleased to announce the results of its annual general meeting ('AGM') of shareholders held on June 12, 2025. Shareholders holding a total of 80,309,202 common shares of the Corporation attended the AGM in person or were represented by proxy, representing approximately 37 % of the 218,274,932 common shares issued and outstanding. Pierre Colas, Jeffrey Hussey, André Le Bel, Amy Satov, Mathieu Savard and Robert Wares were re-elected to the board of directors. The shareholders also (i) approved the re-appointed Raymond Chabot Grant Thornton LLP as auditors for the ensuing financial year, (ii) approved the deferred share unit plan (the 'DSU Plan') adopted by the Corporation's board of directors on April 30, 2025, allowing for a maximum of 2,400,000 common shares to be awarded as deferred share units under the DSU Plan, and (iii) ratified, approved and confirmed the stock option plan, as amended by the Corporation's board of directors on April 30, 2025, allowing for a maximum of 19,400,000 common shares to be subject to stock options under the stock option plan. Collectively, the number of common shares reserved for issuance under all the Corporation's security-based compensation plans, namely the stock option plan and the DSU Plan, represents less than 10% of the Corporation's currently issued and outstanding common shares. The adoption of the DSU Plan and the amendment to the stock option plan remain subject to final approval by the TSX Venture Exchange. About Brunswick Exploration Brunswick Exploration is a Montreal-based mineral exploration company focused on grassroots exploration for lithium in Canada, a critical metal necessary to global decarbonization and energy transition. The Corporation is rapidly advancing the most extensive grassroots lithium property portfolio in Canada and Greenland. Investor Relations/information Mr. Killian Charles, President and Chief Executive Officer (info@ Cautionary Statement on Forward-Looking Information This news release contains 'forward-looking information' within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, delays in obtaining or failures to obtain required governmental, environmental or other project approvals; uncertainties relating to the availability and costs of financing needed in the future; changes in equity markets; inflation; fluctuations in commodity prices; delays in the development of projects; the other risks involved in the mineral exploration and development industry; and those risks set out in the Corporation's public documents filed on SEDAR+ at Although the Corporation believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Corporation disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
China-to-US Freight Rates ‘No Longer Surging'—Is it All Downhill from Here?
After a series of weeks which saw trans-Pacific container prices double in the wake of a tariff truce between the U.S. and China, ocean freight rates may have already hit their summer seasonal peak. According to Hong Kong-based container shipping researcfh firm Linerlytica, rates have peaked after ocean carriers rolled back general rate increases (GRIs) from the previous two weeks as trans-Pacific capacity injections have still exceeded market demand. More from Sourcing Journal As Houthis Warn of 'War' Amid Israel-Iran Tensions, Red Sea Shipping Still Stagnant Trump Likely to Extend Tariff Pause as Negotiations Take Shape, Treasury Secretary Says Trump Touts Higher Duty Rate for Chinese Imports Under New Trade Deal A weekly update on Monday indicated that carriers are 'struggling to fill the ships' on the pathway to Los Angeles-Long Beach. Drewry's World Container Index (WCI), which saw ocean freight rates skyrocket 117 percent on the trans-Pacific trade lane in the four-week span prior to June 5, experienced a paltry 1 percent weekly jump to $5,914 per 40-foot container. The Shanghai-to-New York route had a major stabilization as well, shooting up 96 percent in a four-week span before inching up 2 percent to $7,285 per container. Overall, week-over-week totals across the WCI remained stable at $3,543 per 40-foot container. 'Global container shipping has addressed short-term capacity shortages and spot rates are now no longer surging, which will come as a relief to shippers,' said Philip Damas, head of Drewry Supply Chain Advisors. As carriers resumed suspended services and new carriers entered the market, Asia-to-West Coast ship capacity rose 16 percent month over month in June and is expected to increase another 8 percent in July, 'with far fewer cancelled sailings than in April/May,' Damas told Sourcing Journal. However, while GRI hikes are a lever ocean carriers often pull to capitalize on a surge in cargo and increase freight rates, the increased capacity forced them to pull back a week after taking effect. 'The June 1 GRI was fully implemented but failed to hold,' said Hua Joo Tan, co-founder of Linerlytica. 'Freight rates are dropping from their early June peak and will continue to fall back due to excess capacity as well as the absence of box shortages and port congestion. The mid-June GRI appears to be doomed for the same reasons.' According to a Thursday weekly update from Flexport, carriers have fully withdrawn planned June 15 GRIs for West Coast destinations. On the East and Gulf Coasts, GRIs remain in effect. Not everyone is anticipating such a quick fall, with Xeneta expecting an element of front-loading to still permeate throughout the original 90-day tariff rollback period. Xeneta's chief analyst, Peter Sand, said that 'mid-high' spot rates—rates paid by shippers in the 75th-highest percentile of the spot market—were the first batch that needed to get goods into the U.S. immediately and refill inventory. This cohort drove the sharpest rise in China-to-U.S. demand right after the rollback was announced May 12, he said. 'As we head into the second half of June, shippers benchmarking themselves against mid-low and average freight rates on the trans-Pacific headhaul will have to pay up as well,' Sand told Sourcing Journal. 'Still a tight market, but not tightening further to lift mid-high, as carriers are busy and soon done with bringing capacity back to the trans-Pacific trade lanes.' Adding onto the uncertainty is the U.S.-China tariff situation itself, which is still up in the air despite the Trump administration's insistence that there will be no more changes. Although representatives from the U.S. and China came to a new trade deal on Wednesday that establishes a combined duty rate of 55 percent on imports from China, there have been scant details surrounding the agreement. Additionally, neither Presidents Donald Trump or Xi Jinping have officially approved the deal. 'There are still a lot of moving parts on the tariff front and this is unlikely to be the end as far as China tariffs are concerned,' Tan told Sourcing Journal. 'The cargo volume trajectory will also depend on the rest of tariff discussions that are yet to be finalized.' This refers to the other 90-day deadline for U.S. trade partners that were recipients of the reciprocal tariffs. Treasury Secretary Scott Bessent said Wednesday it is 'highly likely' the July 9 deadline would be extended. But with these de-escalations occurring, rates are likely to go on a downward slope if demand for carrier space weakens. 'Looking ahead, the end of the 90-day tariff pause and the probable early end of the peak season are expected to cause another downcycle in demand, another need for ship capacity changes and another sharp fall in spot freight rates from July,' said Damas.
Yahoo
21 minutes ago
- Yahoo
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note
Viking Therapeutics, Inc. (VKTX) closed at $28.59 in the latest trading session, marking a -1.26% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.38%. On the other hand, the Dow registered a gain of 0.24%, and the technology-centric Nasdaq increased by 0.24%. Prior to today's trading, shares of the company had gained 8.96% outpaced the Medical sector's gain of 4.64% and the S&P 500's gain of 6.6%. The investment community will be paying close attention to the earnings performance of Viking Therapeutics, Inc. in its upcoming release. The company is expected to report EPS of -$0.44, down 120% from the prior-year quarter. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.86 per share and revenue of $25 million, indicating changes of -84.16% and 0%, respectively, compared to the previous year. Investors should also note any recent changes to analyst estimates for Viking Therapeutics, Inc. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Right now, Viking Therapeutics, Inc. possesses a Zacks Rank of #3 (Hold). The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 74, which puts it in the top 31% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Viking Therapeutics, Inc. (VKTX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
